Effective 9/27/24, TEGSEDI^® (inotersen) is no longer available to patients in the US. We encourage you to connect with your patient or healthcare provider on a treatment transition plan. Akcea remains committed to supporting patients through their transition. Please contact Akcea at 1-833-829-9063 with questions about TEGSEDI^®.